Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
155.79
+0.52 (+0.33%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
99
100
Next >
3 Stocks to Buy With 20% Upside
June 08, 2024
All three of these high-quality companies have great upside.
Via
The Motley Fool
The 3 Best Dow Stocks to Buy in June 2024
June 07, 2024
Discover the three best Dow stocks to buy in June 2024. Invest in these top-performing companies with strong fundamentals.
Via
InvestorPlace
Topics
Stocks
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
June 07, 2024
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance...
Via
Benzinga
Uncovering Dividend Opportunities with NYSE:JNJ.
June 07, 2024
Exploring JOHNSON & JOHNSON (NYSE:JNJ)'s dividend characteristics.
Via
Chartmill
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
June 07, 2024
Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty.
Via
InvestorPlace
Performance Comparison: Johnson & Johnson And Competitors In Pharmaceuticals Industry
June 03, 2024
Via
Benzinga
What the Options Market Tells Us About Johnson & Johnson
May 28, 2024
Via
Benzinga
NYSE:JNJ: good value for what you're paying.
May 28, 2024
JOHNSON & JOHNSON (NYSE:JNJ) is probably undervalued for the fundamentals it is displaying.
Via
Chartmill
3 Dow Stocks That Are No-Brainer Buys in June
June 07, 2024
The 30-component Dow Jones Industrial Average has three phenomenal deals hiding in plain sight.
Via
The Motley Fool
Topics
Stocks
Sleep Easy: 3 Safe Stocks That Won’t Have You Stressin’
June 06, 2024
Explore three safe stocks to buy with sharp fundamentals in pharmaceuticals, household products, and restaurants.
Via
InvestorPlace
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
June 04, 2024
From
Johnson & Johnson
Via
Business Wire
The 3 Most Undervalued Dow Stocks to Buy in June 2024
June 04, 2024
Some undervalued Dow stocks are starting to look timely as we enter the last month of the first half of 2024.
Via
InvestorPlace
Topics
Stocks
3 Dividend Aristocrats to Scoop Up During Market Pullbacks in June
June 04, 2024
Since three dividend aristocrat stocks have rewarded shareholders for decades, buy them now for a worry-free retirement.
Via
InvestorPlace
Johnson & Johnson Ordered To Pay $260M In Latest Talc Trial
June 04, 2024
The ruling comes as J&J continues to pursue a proposed $6.48 billion settlement of most talc-related lawsuits through a prepackaged bankruptcy.
Via
Benzinga
Topics
Lawsuit
Johnson & Johnson At ASCO Highlights Long Term Data From Multiple Myeloma Drug, Shows Sustained Deep, Durable Responses In Pretreated Patients
June 03, 2024
JNJ announced positive longer-term data from Phase 1/2 study of Tecvayli for RRMM. Results show deep and durable responses with a consistent safety profile.
Via
Benzinga
7 Overlooked Stocks That Belong in Every Portfolio
June 03, 2024
Looking beyond the headlines creates an opportunity for investors who have the patience to seek must-own overlooked stocks.
Via
InvestorPlace
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
June 01, 2024
Eli Lilly is in a buy zone, while rival Novo Nordisk forged a lower entry.
Via
Investor's Business Daily
Topics
Stocks
3 Magnificent Dividend Stocks to Buy and Hold Forever
June 01, 2024
These dividend stocks are keepers for income investors.
Via
The Motley Fool
Boring Is Beautiful: 3 Blue-Chip Stocks to Buy and Hold Forever
May 31, 2024
Discover why boring blue-chip stocks like Johnson & Johnson, Sysco, and S&P Global can prove to be excellent long-term investments.
Via
InvestorPlace
Topics
Stocks
Johnson & Johnson Completes Acquisition of Shockwave Medical
May 31, 2024
From
Johnson & Johnson
Via
Business Wire
3 Sorry Biotech Stocks to Sell in May While You Still Can
May 31, 2024
Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell.
Via
InvestorPlace
Why Sarepta Therapeutics Stock Is Rising Today
May 30, 2024
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400.
Via
Benzinga
Topics
Stocks
3 Stocks That Could Be Easy Wealth Builders
May 30, 2024
These investment ideas should help you grow your portfolio with minimal effort.
Via
The Motley Fool
Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the Limit
May 30, 2024
Be careful with these overvalued blue-chip stocks, each of which is trading at a high multiple relative to its peers.
Via
InvestorPlace
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial
May 29, 2024
Johnson & Johnson reported successful Phase 3 trial results for seltorexant, an investigational treatment for major depressive disorder with insomnia.
Via
Benzinga
Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare
May 29, 2024
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest wealth transfer in history.
Via
Benzinga
Topics
Economy
Retirement
HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom
May 28, 2024
With innovations constantly being developed in the healthcare space, investors should target these medical technology stocks.
Via
InvestorPlace
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis
May 28, 2024
From
Numab Therapeutics AG
Via
GlobeNewswire
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
May 28, 2024
From
Johnson & Johnson
Via
Business Wire
10 Best Vanguard Funds to Buy Right Now
May 27, 2024
These 10 Vanguard stock ETFs can help you build a top-notch portfolio.
Via
The Motley Fool
Topics
ETFs
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.